Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)


  • The impact of end-stage renal disease on liver disease progression in patients with HCV is not well defined due to high mortality in patients on long-term HD
  • Anti-HCV antibody positivity in patients on long-term HD has been associated with increased risk of death due to cardiovascular disease[Fabrizi 2012]
  • The impact of immunosuppression on HCV disease progression following renal transplantation is unclear:

    Action required